Jipmer enrolls first infant in NeoSep1 international clinical trial in fight against neonatal sepsis

Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

Raccontata dathehindu.com